Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer.
Metaplastic carcinoma of the breast with neuroglial differentiation.
Can breast MRI predict axillary lymph node metastasis in women undergoing neoadjuvant chemotherapy.
Does neoadjuvant bevacizumab increase surgical complications in breast surgery?
Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy?
Current surgical approach to Paget's disease.
Internal mammary nodes in breast cancer: diagnosis and implications for patient management -- a systematic review.
Impact of neoadjuvant chemotherapy on breast reconstruction.
Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
A phase II study of preoperative capecitabine in women with operable hormone receptor positive breast cancer.
Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance).
The effect of Paget disease on axillary lymph node metastases and survival in invasive ductal carcinoma.
Variation in the use of granulocyte-colony stimulating factor for dose dense paclitaxel: A single institution retrospective study.
Factors Associated With Delays in Chemotherapy Initiation Among Patients With Breast Cancer at a Comprehensive Cancer Center.
The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer.
Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial.
Impact of neoadjuvant chemotherapy and pathological complete response on eligibility for breast-conserving surgery in patients with early breast cancer: A meta-analysis.
Impact of Genomic Assay Testing and Clinical Factors on Chemotherapy Use After Implementation of Standardized Testing Criteria.
Prognostic Significance of Residual Axillary Nodal Micrometastases and Isolated Tumor Cells After Neoadjuvant Chemotherapy for Breast Cancer.
Survival Outcomes for Patients With Clinical Complete Response After Neoadjuvant Chemotherapy: Is Omitting Surgery an Option?
Early assessment with magnetic resonance imaging for prediction of pathologic response to neoadjuvant chemotherapy in triple-negative breast cancer: Results from the phase III BrighTNess trial.
Breast Conservation After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Surgical Results From the BrighTNess Randomized Clinical Trial.